Takamiya Tomomasa, Nitta Junichi, Sato Akira, Inamura Yukihiro, Kato Nobutaka, Inaba Osamu, Negi Ken, Yamato Tsunehiro, Matsumura Yutaka, Takahashi Yoshihide, Goya Masahiko, Hirao Kenzo
Department of Cardiology Japanese Red Cross Saitama Hospital Saitama Japan.
Department of Cardiovascular Medicine Tokyo Medical and Dental University Tokyo Japan.
J Arrhythm. 2019 Feb 18;35(2):215-222. doi: 10.1002/joa3.12168. eCollection 2019 Apr.
Little evidence exists regarding the endpoint and optimum approach to catheter ablation for long-standing persistent atrial fibrillation (LSPAF). We examined the efficacy of pulmonary vein isolation (PVI) plus left atrium posterior wall isolation (PWI) and additional non-PV trigger ablation using high-dose isoproterenol for LSPAF.
One-hundred and fifty-five patients (median AF duration, 36 months) underwent catheter ablation for LSPAF; After PVI plus PWI, they underwent provocation of non-PV triggers by high-dose isoproterenol and were divided into 3 groups based on the results: group A, PVI plus PWI alone, without induced non-PV triggers (single procedure: 105 patients, multiple procedures: 90 patients); group B, mappable non-PV triggers demonstrated and ablated (single procedure: 41 patients, multiple procedures: 45 patients); group C, if non-PV triggers were unmappable or could not be induced in repeated procedures, adjunctive complex fractionated atrial electrogram ablation was performed (single procedure: 9 patients, multiple procedures: 20 patients).
The Kaplan-Meier estimate of the 1-year freedom from atrial tachyarrhythmias without antiarrhythmic drugs was 65% in all patients, (73%, 56%, and 11% in groups A, B, and C, respectively) after a single procedure, which improved to 86% in all patients (93%, 86%, and 53% in groups A, B, and C, respectively) after multiple procedures.
Even for LSPAF, in approximately 60% of patients, non-PV triggers were not elicited, and PVI plus PWI alone achieved good outcomes. Although the inducibility of non-PV triggers was associated with recurrence of atrial tachyarrhythmias, additional non-PV trigger ablation may improve the outcome after multiple procedures.
关于长期持续性房颤(LSPAF)导管消融的终点和最佳方法,现有证据较少。我们研究了肺静脉隔离(PVI)加左心房后壁隔离(PWI)以及使用高剂量异丙肾上腺素进行额外非肺静脉触发灶消融治疗LSPAF的疗效。
155例患者(房颤持续时间中位数为36个月)接受了LSPAF导管消融治疗;在PVI加PWI之后,他们接受高剂量异丙肾上腺素激发非肺静脉触发灶,并根据结果分为3组:A组,仅行PVI加PWI,未诱发出非肺静脉触发灶(单次手术:105例患者,多次手术:90例患者);B组,显示并消融可标测的非肺静脉触发灶(单次手术:41例患者,多次手术:45例患者);C组,如果非肺静脉触发灶不可标测或在重复手术中无法诱发,则进行辅助性碎裂心房电图消融(单次手术:9例患者,多次手术:20例患者)。
在单次手术后,所有患者在不使用抗心律失常药物的情况下,1年无房性快速性心律失常的Kaplan-Meier估计值为65%(A组、B组和C组分别为73%、56%和11%),多次手术后所有患者该值提高到86%(A组、B组和C组分别为93%、86%和53%)。
即使对于LSPAF,约60%的患者未诱发出非肺静脉触发灶,仅PVI加PWI就能取得良好疗效。尽管非肺静脉触发灶的可诱发性与房性快速性心律失常的复发有关,但额外的非肺静脉触发灶消融可能会改善多次手术后的结局。